Malignant Anorectal Neoplasm — Trials

Malignant Anorectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 452
Recruiting: 249
Ph III recruiting: 38
Growth YoY: +8.5%
Industry share: 6%
Top sponsor: Fudan University
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (174)

clinicaltrialsPublishedShowing 1–16 of 16 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06459869	NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer(FORTRESS)	active not recruiting	Phase 1	30	Akamis BioINDUSTRY	2	Sep 16, 2026	clinicaltrials
NCT02381561	Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy	active not recruiting	Phase 1	19	National Cancer Institute (NCI)NIH	1	Sep 15, 2026	clinicaltrials